Subclinical Alterations in Coagulation and Fibrinolysis in Patients Undergoing Autologous Peripheral Blood Stem Cell Transplantation

References

• Rogers J. S., Murgo A. J., Fontana J. A., Raich P. C. Chemotherapy for breast cancer decreases plasma protein C and protein S. J. Clin. Oncol 1988; 6: 276–281
   PubMed Web of Science ®Google Scholar
• Weiss R. B., Tormey D. C., Holland J. F., Weinberg V. E. Venous thrombosis during multimodal treatment of primary breast carcinoma. Cancer Treat. Rep. 1981; 65: 677–679
   PubMedGoogle Scholar
• Kuzel T., Esparez B., Green D., Kies M. Thrombogenicity of intravenous 5-fluorouracil alone or in combination with cisplatin. Cancer 1990; 65: 885–889
   PubMed Web of Science ®Google Scholar
• McDonald G. B., Sharma P., Matthews D. E., Shulman H. M., Thomas E. D. Venocclusive disease of the liver after bone marrow transplantation: Diagnosis, incidence, and predisposing factors. Hepatology 1984; 4: 116–122
   PubMed Web of Science ®Google Scholar
• McDonald G. B., Hinds M. S., Fisher L. D., Schoch H. G., Wolford J. L., Banaji M., Hardin B. J., Shulman H. M., Clift R. A. Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: A cohort study of 355 patients. Ann. Int. Med. 1993; 118: 255–267
   PubMed Web of Science ®Google Scholar
• Shulman H. M., McDonald G. B. Liver disease after marrow transplantation. The Pathology of Bone Marrow, G. E. Sale, H. M. Shulman. Masson, New York 1984; 104
   Google Scholar
• Ayash L. J., Hunt M., Antman K., Nadler L., Wheeler C., Takvorian T., Elias A., Antin J. H., Greenough T., Eder J. P. Hepatic veno-occlusive disease in autologous bone marrow transplantation of solid tumors and lymphomas. J. Clin. Oncol. 1990; 8: 1699–1706
   PubMed Web of Science ®Google Scholar
• Juttner C. A., To L. B., Haylock D. N., Branford A., Kimber R. J. Circulating autologous stem cells collected in very early remission from acute non-lymphoblastic leukaemia produce prompt but incomplete haemopoietic reconstitution after high dose melphalan or supralethal chemoradiotherapy. Br. J. Haematol. 1985; 61: 739–745
   PubMed Web of Science ®Google Scholar
• Juttner C. A., To L. B., Dyson P., Haylock D. N., Branford A., Kimber R. J. The peripheral blood CFU-Mix: CFU-GM ratio during very early remission from acute non-lymphoblastic leukemia. Br. J. Haematol. 1986; 62: 598–599, (letter)
   PubMed Web of Science ®Google Scholar
• Asakura H., Kamikubo Y., Goto A., Shiratori Y., Yamazaki M., Jokaji H., Saito M., Uotani C., Kumabashiri I., Morishita E., Nakamura S., Matsuda T. Role of tissue factor in disseminated intravascular coagulation. Thromb.Res. 1995; 80: 217–224
   PubMed Web of Science ®Google Scholar
• Bazarbachi A., Scrobohaci M. L., Gisselbrecht C., Marolleau J. P., Mansi A., Brice P., Gorra P., Drouet L. Changes in protein C., factor VII and endothelial markers after autologous bone marrow transplantation: possible implications in the pathogenesis of veno-occlusive disease. Nouv. Rev. Fr. Hematol 1993; 35: 135–140
   PubMedGoogle Scholar
• Collins P., Roderick A., O'Brien D., Tuddenham E., O'Driscoll A., Chopra R., Goldstone A., Newland A. Factor VIIa and other haemostatic variables following bone marrow transplantation. Thromb. Haemost. 1994; 72: 28–32
   PubMed Web of Science ®Google Scholar
• Scrobohaci M. L., Drouet L., Monem-Mansi A., Devergie A., Baudin B., D'Agay M. F., Gluckman E. Liver veno-occlusive disease after bone marrow transplantation changes in coagulation parameters and endothelial markers. Thromb. Res. 1991; 63: 509–519
   PubMed Web of Science ®Google Scholar
• Vannucchi A. M., Rafanelli D., Longo G., Bosi A., Guidi S., Saccardi R., Filimberti E., Cinotti S., Grossi A., Morfini M. Early hemostatic alterations following bone marrow transplantation: A prospective study. Huematologica 1994; 79: 519–525
   PubMedGoogle Scholar
• Salat C., Holler E., Reinhardt B., Kolb H. J., Seeber B., Ledderose G., Mittermueller J., Duell T., Wilmanns W., Hiller E. Parameters of the fibrinolytic system in patients undergoing BMT: elevation of PAI-1 in veno-occlusive disease. Bone Marrow Transplant. 1994; 14: 747–750
   PubMed Web of Science ®Google Scholar
• Gordon B., Haire W., Kessinger A., Duggan M., Armitage J. High frequency of antithrombin 3 and protein C deficiency following autologous bone marrow transplantation for lymphoma. Bone Marrow. Transplant. 1991; 8: 497–502
   PubMed Web of Science ®Google Scholar
• Rodeghiero F., Mannucci P. M., Vigano S., Barbui T., Gugliotta L., Cortellaro M., Dini E. Liver dysfunction rather than intravascular coagulation as the main cause of low protein C and antithrombin III in acute leukemia. Blood 1984; 63: 965–969
   PubMed Web of Science ®Google Scholar
• Griffin J. H., Mosher D. F., Zimmerman T. S., Kleiss A. J. Protein C., an antithrombotic protein, is reduced in hospitalized patients with intravascular coagulation. Blood 1982; 60: 261–264
   PubMed Web of Science ®Google Scholar
• Marlar R. A., Neumann A. Neonatal purpura fulminans due to homozygous protein C- or protein S-deficiencies. Semin. Thromb. Hemost. 1990; 16: 299–309
   PubMed Web of Science ®Google Scholar
• Tanabe S., Sugo T., Matsuda M. Synthesis of protein C in human umbilical vein endothelial cells. J. Bioche. 1991; 109: 924–928
   PubMed Web of Science ®Google Scholar
• van Hinsbergh V. W., Kooistra T., van den Berg E. A., Princen H. M., Fiers W., Emeis J. J. Tumor necrosis factor increases the production of plasminogen activator inhibitor in human endothelial cells in vitro and in rats in vivo. Blood 1988; 72: 1467–1473
   PubMed Web of Science ®Google Scholar
• Takahashi H., Ito S., Hanano M., Wada K., Niwano H., Seki Y., Shibata A. Circulating thrombomodulin as a novel endothelial cell marker: Comparison of its behavior with von Willebrand factor and tissue-type plasminogen activator. Am. J. Hematol. 1992; 41: 32–39
   PubMed Web of Science ®Google Scholar
• Ishii H., Majerus P. W. Thrombomodulin is present in human plasma and urine. J. Clin. Invest. 1985; 76: 2178–2181
   PubMed Web of Science ®Google Scholar
• Cozzolino F., Torcia M., Miliani A., Carossino A. M., Giordani R., Cinotti S., Filimberti E., Saccardi R., Bernabei P., Guidi G. Potential role of interleukin-1 as the trigger for diffuse intravascular coagulation in acute nonlym-phoblastic leukemia. Am. J. Med. 1988; 84: 240–250
   PubMed Web of Science ®Google Scholar
• Conway E. M., Nowakowski B., Steiner-Mosonyi M. Human neutrophils synthesize thrombomodulin that does not promote thrombin-dependent protein C activation. Blood 1992; 80: 1254–1263
   PubMed Web of Science ®Google Scholar
• Nawroth P. P., Stem D. M. Endothelial cell pro-coagulant properties and the host response. Semin. Thromb. Hemost. 1987; 13: 391–397
   PubMed Web of Science ®Google Scholar
• Asakura H., Jokaji H., Saito M., Uotani C., Kumabashiri I., Morishita E., Yamazaki M., Matsuda T. Changes in plasma levels of tissue-plasminogen activator/inhibitor complex and active plasminogen activator inhibitor in patients with disseminated intravascular coagulation. Am. J. Hematol. 1991; 36: 176–183
   PubMed Web of Science ®Google Scholar